Robeco Institutional Asset Management B.V.
Position in ELAN — Elanco Animal Health Inc
CIK 1418773
ROTTERDAM, P7
Position in ELAN
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$4,282,213
+$108,534 QoQ
Shares Held
174,003
-0.2% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#139
of 518 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 8%
Shared 0%
None 92%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Robeco Institutional Asset Management B.V. holds $403,524,623 across 13 Drug Manufacturers - Specialty & Generic names. ELAN ranks #7 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RDY |
Dr Reddys Laboratories Ltd
|
18,021,100 | $261,125,739 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
123,056 | $66,675,432 | |
| 3 | VTRS |
Viatris Inc
|
2,080,468 | $33,037,831 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
107,976 | $18,198,275 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
128,116 | $5,256,599 | |
| 6 | ALKS |
Alkermes plc.
|
92,592 | $4,851,357 | |
| 7 | ELAN |
Elanco Animal Health Inc
This page
|
174,003 | $4,282,213 | |
| 8 | PCRX |
Pacira BioSciences, Inc.
|
164,014 | $4,161,035 |
All Filings in ELAN
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,282,213 | 174,003 | Shares | Defined | 2026-07-21 | |
| 2026-03-31 | $4,173,679 | 174,412 | Shares | Defined | 2026-04-21 | |
| 2025-12-31 | $3,946,943 | 174,412 | Shares | Defined | 2026-01-23 | |
| 2024-03-31 | $1,919,656 | 117,915 | Shares | Defined | 2024-04-24 | |
| 2023-03-31 | $13,368,614 | 1,422,193 | Shares | Defined | 2023-05-04 | |
| 2022-12-31 | $17,375,911 | 1,421,924 | Shares | Defined | 2023-02-07 | |
| 2022-09-30 | $17,931,692 | 1,444,939 | Shares | Defined | 2022-12-01 | |
| 2022-06-30 | $23,131,226 | 1,178,361 | Shares | Defined | 2022-12-01 | |
| 2022-03-31 | $30,037,051 | 1,151,286 | Shares | Defined | 2022-12-01 | |
| 2021-12-31 | $117,550,669 | 4,142,025 | Shares | Defined | 2022-12-01 | |
| 2021-09-30 | $151,323,535 | 4,745,172 | Shares | Defined | 2022-12-01 | |
| 2021-06-30 | $125,959,840 | 3,631,013 | Shares | Defined | 2022-12-01 | |
| 2021-03-31 | $2,406,447 | 81,713 | Shares | Defined | 2022-12-01 | |
| 2020-12-31 | $2,294,330 | 74,807 | Shares | Defined | 2022-12-01 | |
| 2020-09-30 | $1,826,817 | 65,407 | Shares | Defined | 2021-01-19 | |
| 2020-06-30 | $1,271,706 | 59,287 | Shares | Defined | 2021-01-19 | |
| 2020-03-31 | $1,449,640 | 64,745 | Shares | Defined | 2021-01-19 | |
| No filing history on record for this holder in this stock. | ||||||